var  groupallo = {
    "feature_count": 704,
    "type": [
        "FeatureCollection"
    ],
    "features": [
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183622",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-06-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease",
                "aff": "Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02580617",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 67, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04497805",
                "enrolled": 64,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 73, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-01-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394886",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 104, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2014-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03754465",
                "enrolled": 56,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 68, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2019-01-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183648",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 106, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-06-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.",
                "aff": "Korea University Kuro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03370874",
                "enrolled": 164,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 60, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2018-07-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Korea University Guro Hospital, Guro-gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 86, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Eulji General Hospital, Nowon-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 86, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Severance Hospital, Seodaemun-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 86, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Asan medical center, Songpa-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 86, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394873",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 103, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",
                "aff": "Section of Colon and Rectal Surger, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02384499",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 89, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-03-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619851",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 61, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03449082",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 90, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2018-05-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Mesenchymal Stem Cells",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01856140",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 99, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-05-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 103, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 103, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Samsung medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 103, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 103, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.",
                "aff": "University of Texas Rio Grande Valley School of Medicine, Harlingen, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03265808",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 81, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2018-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 63, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 63, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery",
                "aff": "ISCI/University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02065245",
                "enrolled": 65,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2014-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02886884",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 73, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)",
                "aff": "ISCI / University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02013674",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 106, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2014-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 96, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 96, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 96, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 96, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.",
                "aff": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01956903",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 93, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2010-09-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 76, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2013-05-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Instituto de Biologia y Genetica Molecular, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 76, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2013-05-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Centro Medico Teknon, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 87, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 87, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2012-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",
                "aff": "University Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01678534",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 81, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital de Jerez de la Frontera., Jerez de la Frontera, C\u00e1diz., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 104, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 104, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen del Roc\u00edo de Sevilla, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 104, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Cl\u00ednico de Valencia, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 104, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Valle de Hebr\u00f3n, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 77, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Fundaci\u00f3n Jim\u00e9nez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 77, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 77, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 58, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 58, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2017-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Centre for Liver Research & Diagnostics, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    15
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Mediciti Hospital, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    15
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Manipal Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "KMC Hospital, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Institute of liver disease, HPB surgery and transplant Global Hospitals, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Bombay Hospital & Medical Research Center, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Ruby Hall clinic, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Sahyadri Speciality Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SMS Medical college and Hospital, Jaipur, Rajasthan, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    75,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SGPGI Lucknow, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 60, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT02336646",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 107, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2015-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04382547",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 73, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-05-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03522545",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 83, 30)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells",
                "aff": "Saint-Louis Hospital, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02213705",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 85, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of California San Francisco Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 105, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Stanford University Medical Center, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 105, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 105, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 105, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "Mercy Gilbert and Chandler Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 107, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California Irvine Department of Neurology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 107, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California San Diego Division of Neurological Surgery, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 107, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04776239",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 88, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells",
                "aff": "University of Illinois, Department of Ophthalmology and Visual Sciences, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04626583",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 78, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Clinica Universitaria de Navarra, Av Pio XII ,36, Pamplona, Navarra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 57, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 57, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 57, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 57, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital clinico universitario de salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 57, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Virgen del Rocio University Hospital, av. Manuel Siurot s/n, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 57, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Minnesota Medical Center, Saint Paul, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 71, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10757 - Cardiology, P.C., Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa, Mesa, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10756 - Mayo Clinic, Phoenix, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -112,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13023 - University of Arizona Medical Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10754 - University of California, San Diego, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10759 - Scripps Clinic, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13265 - University of California, Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10778 - Orange County Cardiology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13031 - St. John's Regional Medical Center, Oxnard, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -119,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13275 - Stanford University Hospital, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13267 - Bethesda Heart Hospital, Boynton Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10780 - Morton Plant Hospital, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13273 - University of Florida Health, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10768 - University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13280, Orlando, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13027 - Emory University School of Medicine, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10765 - Georgia Regents University, Augusta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13030 - University of Iowa, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13022 - University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13266, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10782, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10762 - Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10761 - Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13281, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center, Newark, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10776 - Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10781 - Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10758 - The Christ Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10770 - University of Cincinnati, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10773, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13278 - OhioHealth Research Institute, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10785 - Lehigh Valley Hospital, Allentown, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13261 - University of Pennsylvania, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10767 - Temple University Hospital, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13277, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10774 - University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13024 - Austin Heart, PLLC, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10755 - Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13268 - Houston Methodist Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10763 - University Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10764 - University of Wisconsin, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10769 - Aurora Healthcare, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13279, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10789 - Aspirus Research Institute, Wausau, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11027, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11024 - Victoria Heart Institute Foundation, Victoria, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11025 - St. Michael's Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 67, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12967,
                "paneLabel": "pane12967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04388761",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 66, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease",
                "aff": "Children's National Medical Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02150551",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 82, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2015-05-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03929120",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-10-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05286255",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 73, 53)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-05-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Immunotherapy for Septic Shock: A Phase I Trial",
                "aff": "The Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02421484",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 82, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital General de Alicante, Alicante, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Gregorio Mara\u00f1on, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "La Paz University Hospital, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Clinica Universidad de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario de Salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Victoria Eugenia Cruz Roja Espa\u00f1ola, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital de Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 74, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 72, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 72, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02298023",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 84, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT01649687",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 82, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2012-07-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, C\u00e1diz, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 70, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 70, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 70, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 70, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Unversitario Virgen del Roc\u00edo, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 70, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Nuestra Se\u00f1ora de Valme, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 70, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Pinnacle Research Group, Anniston, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthrocare Arthritis Care and Research PC, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Triwest Research Associates, El Cajon, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Inland Rheumatology Clinical Trials Incorporated, Upland, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Ocala Rheumatology Research Center, Ocala, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Center, Palm Harbor, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Sarasota Arthritis Research Center, Sarasota, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "McIlwain Medical Group, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "JHU Arthritis Center Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Treatment Center, Frederick, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Reliant Medical Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Office of Ramesh C. Gupta, MD, Fair Lawn, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "DJL Clinical Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Health Research of Oklahoma, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "West Tennessee Research Institute, Jackson, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Accurate Clinical Research, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Texas Arthritis Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Southern Clinical Research Pty Ltd, Hobart, Tasmania, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    147,
                    -42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Emeritus Research, Malvern, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 60, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis",
                "aff": "Department of Gastroenterology; Gulhane Military Medical Academy, Ankara, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT01378182",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 68, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2011-06-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B",
                "aff": "Cipto Mangunkusumo hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04357600",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 105, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-05-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus",
                "aff": "Universidad de Chile Clinical Hospital, Santiago, Independencia, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03905824",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 80, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2019-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 62, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 62, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, M. S. Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, Kasturba Medical College, Manipal, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Jehangir Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Immunology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 69, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease",
                "aff": "University of Malaya Medical Centre, Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05039411",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 93, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2022-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02611167",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 66, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis",
                "aff": "Hanyang university hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03174587",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 87, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2017-05-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05532943",
                "enrolled": 41,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 77, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-11-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05501418",
                "enrolled": 75,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 80, 51)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2022-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation",
                "aff": "Indiana University, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02685098",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 76, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-02-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 91, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 91, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04835883",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 104, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-08-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, Delhi, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity, Gurgaon, Haryana, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Peripheral Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgery, KMC, Mangalore, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Madras Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Sri Ramchandra Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Stanley Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, AMRI Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Nightingale Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 64, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "MedStar Washington Hospital Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 72, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Emory University Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 72, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Northwestern University Centers for Heart Failure Therapy, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 72, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Stony Brook Heart Institute, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 72, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Hospital of the University of Pennsylvania, Heart Failure and Transplant Program, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 72, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia",
                "aff": "The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04255147",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 74, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-02-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04056819",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 106, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Pantai Cheras Medical Centre, Kuala Lumpur, Federal territory, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Serdang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    2
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "KPJ Ampang Puteri Specialist Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    2
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Selayang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    2
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)",
                "aff": "Asthma and Allergy Consultants, Wichita, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02235844",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 93, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12989,
                "paneLabel": "pane12989",
                "start": "2014-08-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Moewardi General Hospital, Surakarta, Central Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 72, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Hasan Sadikin, Bandung, West Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 72, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    107,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Sardjito General Hospital, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 72, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes",
                "aff": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03406585",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 58, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2017-10-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04939077",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 92, 57)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2019-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD).",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04995081",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 97, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-07-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro",
                "aff": "University Clinical Hospital of Salamanca, Salamanca, Salamanca/Castilla Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02104440",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 97, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2013-04-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB",
                "aff": "GangnamSeverance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04520022",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 67, 18)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2016-09-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell and Conditioned Medium for Cerebral Palsy",
                "aff": "Indonesian National Brain Center, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04314687",
                "enrolled": 78,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 96, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2021-09-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury",
                "aff": "Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05016011",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 95, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic MSC Treatment for Pulmonary Emphysema",
                "aff": "Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT04918706",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 58, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2019-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients",
                "aff": "Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04336254",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 104, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients",
                "aff": "Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04535856",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 72, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-10-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    -5
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue",
                "aff": "Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03798353",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 86, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells",
                "aff": "Medical University of Warsaw, Department of Diabetology and Internal Diseases, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03865394",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 95, 43)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2019-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of UCB and MSCs in Children With CP: ACCeNT-CP",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03473301",
                "enrolled": 91,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 61, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2018-04-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03684122",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 58, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04869397",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 65, 47)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-06-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05126563",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 83, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2022-01-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis",
                "aff": "Unidad de Terapia Celular del Instituto de Investigaciones Cient\u00edficas, San Antonio de los Altos, Miranda, Venezuela",
                "url": "https://ClinicalTrials.gov/show/NCT04545307",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 85, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -66,
                    10
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD",
                "aff": "University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05333029",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-04-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02192749",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 65, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    8
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04410731",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 100, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Soffer Health Institute, Aventura, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Panax Clinical Research, Miami Lakes, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Advanced Research for Health Improvement, LLC, Naples, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 105, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy to Improve Burn Wound Healing",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02104713",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 90, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2014-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04548583",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 74, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-10-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease",
                "aff": "Vinmec International Hospital Times City, H\u00e0 N\u1ed9i, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT04433104",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 72, 41)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-06-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04543994",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 83, 10)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Optimal Research LLC, Rockville, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 85, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Alzheimer's Disease Stem Cells Multiple Infusions",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04040348",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 79, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2019-09-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Miami Baptist Hospital, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 85, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Sanford Research, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 85, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2020-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Hospital, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Centers - BMT, Kansas City, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "The Cancer Center at Hackensack University, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mt. Sinai Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, FEC, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Emory University/Childen's Healthcare of Atlanta, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Johns Hopkins University Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Utah/Heart Center-Primary Children's Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 57, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 106, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Sardjito Hospital, Yogyakarta, Special Region, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 106, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05075811",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 93, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-02-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis",
                "aff": "Clinica Universidad de los Andes, Santiago, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT02580695",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 73, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy",
                "aff": "Yan'an Hospital of Kunming City, Kunming, China",
                "url": "https://ClinicalTrials.gov/show/NCT04125329",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 70, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    102,
                    24
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 60, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 60, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 102, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Children's Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 102, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Shanghai First Maternity and Infant Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 102, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05345418",
                "enrolled": 158,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 101, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12978,
                "paneLabel": "pane12978",
                "start": "2022-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife\u00ae-LDP) for Lumbar Discogenic Pain",
                "aff": "Xuanwu Hospital Capital Medical University, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04104412",
                "enrolled": 242,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 95, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2019-08-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05227846",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 73, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2022-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI",
                "aff": "The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02481440",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 104, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2018-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05331872",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 59, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease",
                "aff": "Li Yu, Shenzhen, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05152160",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 63, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-CSD) Therapy for Patients With Healing Poor After Uterus Injury",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03386708",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 103, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19",
                "aff": "Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico",
                "url": "https://ClinicalTrials.gov/show/NCT04456361",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 68, 21)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2020-04-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04441658",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 61, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-04-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
                "aff": "Shanghai Sixth People's Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05468502",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 104, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2022-07-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect",
                "aff": "The Fifth Affiliated Hospital Immunotherapy center, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02291926",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 79, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction\uff08PRIME-HFrEF Study\uff09",
                "aff": "Heart Failure Department, East Hospital Affiliated to Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04992832",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 75, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2021-07-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04996966",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 63, 48)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 85, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 85, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 85, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 85, 17)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03745417",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 77, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2021-10-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02034188",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 61, 27)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2014-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    8
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease",
                "aff": "Shanghai East Hospital, Shanghai, Pudong New Area, China",
                "url": "https://ClinicalTrials.gov/show/NCT05262829",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 83, 58)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2022-02-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-UT) Therapy for Patients With Thin Endometrial Infertility",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05495711",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 96, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells to Treat Type 2 Diabetes",
                "aff": "Chinese PLA General Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02302599",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 91, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2013-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke",
                "aff": "Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04811651",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 57, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2021-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    123,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04314011",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 96, 29)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2020-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02277145",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 92, 36)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2014-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 83, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2016-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "Nanjing Chest Hosptial, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 83, 35)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2016-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 82, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT03945487",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 61, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2019-05-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients",
                "aff": "Gang Li, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04093336",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 75, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2019-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama at Birmingham, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Arizona Cancer Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "City of Hope, Duarte, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Yale New Haven Hospital, New Haven, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "All Children's Hospital, Saint Petersburg, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Illinois - Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana Blood and Bone Marrow Transplant Center, Beech Grove, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Kansas Medical Center, Kansas City, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Louisiana State University, Shreveport, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Maryland/Greenbaum, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts-New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana-Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Karmanos/Wayne State University, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Nebraska, Omaha, Nebraska, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hackensack University Medical Center, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Columbia University/New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest Univeristy School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oregon Health and Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Cancer Center at Medical City, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth/Massey Cancer Center, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Wisconsin Madison, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Co-Medica Research Network, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "British Columbia's Children's Hospital, Vancouver, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Cancer Care Manitoba, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -63,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hamilton Health Sciences Centre, Hamilton, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "London Health Sciences Centre- Westminster Campus, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Toronto General Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital Enfant-Jesus, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital du Saint-Sacrement, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Universia degli Studi di Pesaro, Pesaro, PU, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "IRCCS Policlinico San Matteo, Pavia, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kantonsspital Basel, Basel, Switzerland",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barts & London School of Medicine, London, England, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "John Radcliffe Hospital, Headington, Oxford, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Bristol Royal Hospital for Children, Bristol, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Glasgow Royal Infirmary, Glasgow, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Leeds General Infirmary, Leeds, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 103, 44)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12974,
                "paneLabel": "pane12974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia",
                "aff": "Yunfei Chen, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT04014166",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 91, 42)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2019-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00823316",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 79, 39)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2008-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium",
                "aff": "Sir Run Run Shaw hopital,School of medicine,Zhejiang University, Hangzhou, China",
                "url": "https://ClinicalTrials.gov/show/NCT03724617",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 104, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2018-09-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of UC-MSC Transfusion for ACLF Patients",
                "aff": "Ren Ji Hospital, School of Medicine, Shanghai Jiao TongUniversity,, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04822922",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 72, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02398370",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 71, 26)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2013-03-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02395029",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 99, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2013-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03181087",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 62, 11)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants",
                "aff": "National Chen-Kung University Hospital, Tainan City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03631420",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 62, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Al-Zahra Heart Hospital, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 63, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Faghihi Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 63, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Namazee Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 63, 20)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12975,
                "paneLabel": "pane12975",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis",
                "aff": "The Prince Charles Hospital, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01385644",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 77, 32)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2010-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety and The Efficacy Evaluation of NEUROSTEM\u00ae-AD in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297218",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 67, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of PNEUMOSTEM\u00ae in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02381366",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 77, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2015-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Alabama, Division of Endocrinology & Metabolism, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Scripps Whittier Diabetes Institute, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Diabetes Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Minnesota, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Desert Endocrinology CRC, Henderson, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Nevada Alliance Against Diabetes, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of North Carolina Diabetes Care Center, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "American Health Research, Inc., Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Lindner Clinical Trial Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Providence Health Partners - Center for Clinical Research, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Cumberland Valley Endocrinology, Carlisle, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "AM Diabetes & Endocrinology Center, Bartlett, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The University of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Optimum Clinical Research, Inc., Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Strelitz Diabetes Center, Eastern VA Medical School, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Wisconsin Health- West Clinic, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Clinical and Transitional Science Institute, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 78, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research",
                "aff": "SAHZU, Hanzhou, Zhejiang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04951882",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 96, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-06-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploratory Efficacy Study of NEUROSTEM\u00ae in Subjects Who Control Group of NEUROSTEM\u00ae",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04954534",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 106, 25)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2021-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02968459",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 65, 52)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12980,
                "paneLabel": "pane12980",
                "start": "2021-10-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Maryland, Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Chevy Chase Clinical Research, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Melbourne Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Health Science Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Otago, Christchurch, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    172,
                    -43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Waikato Hospital, Hamilton, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 98, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12972,
                "paneLabel": "pane12972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    175,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial",
                "aff": "UC Davis Health, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04652908",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 85, 59)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2021-06-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of UC-MSCs for COVID-19 Patients",
                "aff": "Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04355728",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 58, 13)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2020-04-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Evaluation of PNEUMOSTEM\u00ae Treatment in Premature Infants With Bronchopulmonary Dysplasia",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297205",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 108, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2010-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Advanced Clinical Research Institute, Anaheim, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Veteran's Administration Medical Center (does not require vet status), Long Beach, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of Connecticut, Hamden, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Venture Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Metropolitan Gastroenterology Group, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Research Associates, Cedar Knolls, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Holy Name Hospital, Teaneck, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dayton Science Institute, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Memorial Hermann Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Health Sciences Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 70, 14)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Exploratory Efficacy Study of NEUROSTEM\u00ae Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02054208",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 95, 46)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2014-02-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 106, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 106, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 106, 9)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12982,
                "paneLabel": "pane12982",
                "start": "2020-07-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Brain Matters Research, Delray Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 97, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 97, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Miami Jewish Health, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 97, 31)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2016-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mercy Gilbert Medical Center / Catholic Health Care West, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Arizona, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UC Davis Medical Center, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of California - San Diego (UCSD), San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mount Sinai Medical Center, Miami Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Care Group, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Maryland Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Tufts Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Baystate Medical Center, Springfield, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMass Memorial Medical Center, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "William Beaumont Hospital, Royal Oak, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University at Buffalo - Buffalo General Hospital, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Stony Brook University Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Lindner Research Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Ohio State University Medical Center, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Penn State University - Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Drexel University College of Medicine, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Allegheny General Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Stern Cardiovascular Center, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Austin Heart P.A., Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Fletcher Allen Health Care, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Wisconsin School of Medicine, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 57, 24)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12976,
                "paneLabel": "pane12976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Stem Cell Therapy in Patients With Autism",
                "aff": "Shandong Jiaotong Hospital, Jinan, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT01343511",
                "enrolled": 37,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 65, 23)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2009-04-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "David Geffen School of Medicine at UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "American Health Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Upstate Pharmaceutical Research, Greenville, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Spartanburg Medical Research, Spartanburg, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Vermont Lung Center, University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 100, 22)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Prochymal\u00ae for the Salvage of Treatment-Refractory Acute GVHD Patients",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00284986",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 88, 38)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12987,
                "paneLabel": "pane12987",
                "start": "2005-10-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Andrews Institute, Gulf Breeze, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "The Emory Clinic, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Fargo, North Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 74, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12969,
                "paneLabel": "pane12969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Biochemical Correction of Severe EB by Allo HSCT and \"Off-the-shelf\" MSCs",
                "aff": "University of Minnesota Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01033552",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 66, 49)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2010-11-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia",
                "aff": "Dankook University Hospital, Cheonan, Chung Nam, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03676400",
                "enrolled": 84,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 93, 50)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12981,
                "paneLabel": "pane12981",
                "start": "2018-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intra-Osseous Co-Transplant of UCB and hMSC",
                "aff": "Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02181478",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 75, 16)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12988,
                "paneLabel": "pane12988",
                "start": "2015-07-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)",
                "aff": "Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03042143",
                "enrolled": 129,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 105, 56)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12979,
                "paneLabel": "pane12979",
                "start": "2019-01-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Menstrual Blood Stem Cells in Severe Covid-19",
                "aff": "Avicenna Research Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05019287",
                "enrolled": 29,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 90, 33)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2021-04-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama Birmingham (UAB) Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "UCLA Medical Center, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of California Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rocky Mountain Cancer Center, Denver, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Chicago Hospitals, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Loyola University Medical Center, Maywood, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana University Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Medical Center, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Center, Lee's Summit, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Washington University School of Medicine, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of North Carolina Hospitals, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University Health System, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Jewish Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Thomas Jefferson University, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oncology Hematology Association, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Pittsburgh Cancer Centers, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina(MUSC), Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Vincent's Hospital, Darlinghurst, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Peter Lougheed Centre, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 64, 54)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12977,
                "paneLabel": "pane12977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04723303",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 61, 55)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12986,
                "paneLabel": "pane12986",
                "start": "2021-09-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of California at San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Alfred I. DuPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Albert Einstein College of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Oregon University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Fred Hutchinson Cancer Research, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 70, 37)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12983,
                "paneLabel": "pane12983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Europ\u00e9en Georges Pompidou - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 69, 40)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12984,
                "paneLabel": "pane12984",
                "start": "2020-04-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "CHOC Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "UCSF Benioff Children's Hospital, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Alfred I. duPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "The Children's Hospital at Montefiore, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Fred Hutchinson Cancer Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 103, 12)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 12985,
                "paneLabel": "pane12985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        }
    ]
}